We are live on
!
Find out more
VIVE
VIVEVE MED INC
VIVE
VIVE
Delisted
VIVE was delisted on the 18th of January, 2023.
20 hedge funds and large institutions have $413K invested in VIVEVE MED INC in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
11% more funds holding
Funds holding: 18 → 20 (+2)
38% less capital invested
Capital invested by funds: $665K → $413K (-$252K)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$21.9K |
| 2 |
VF
Virtu Financial
New York
|
+$19.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$13K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.38K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.35K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$25.2K |
| 2 |
Two Sigma Advisers
New York
|
-$24K |
| 3 |
E
Ergoteles
New York
|
-$18K |
| 4 |
Millennium Management
New York
|
-$2.31K |
| 5 |
Citigroup
New York
|
-$726 |
